VERU — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Veru Inc.
Healthcare · $2.47
1.0
/10
Poor Entry
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bearish
vs SMA200
SMA200 Distance
-1.0%
Below trend
Volatility
Low
Thin premiums
Momentum
Positive
4th day
About Veru Inc.
Veru is a late-stage biopharma developing obesity and cardiometabolic drugs. Micro-cap penny stock, highly speculative with binary clinical trial catalysts. No dividend. Thin options liquidity and wide bid-ask spreads make CSP selling impractical; extreme gap risk on trial data readouts.
Biotechnology
Market Cap
$42M
P/E Ratio
—
Beta
-1.20
Forward P/E
-2.7
52-Week Range Current: $2.47
$2.05 $7.33

VERU — at the 8th percentile of the yearly range, premium quality and downside exposure move together. Historical base-rates show sizing discipline mattering more than premium chasing in this configuration.

Based on end-of-day market dataScored by ThetaLoop Research
VERU ranks #37 of 66 Healthcare tickers by put-selling score (617 total screened)

Position Size & Yield Calculator

Live model for VERU — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0 —
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
ELV Elevance Health, Inc. 8.7 JNJ Johnson & Johnson 8.7 REGN Regeneron Pharmaceuticals, Inc. 8.0 CNC Centene Corporation 7.9 MRK Merck & Co., Inc. 7.2 Browse all Healthcare tickers →
📌 Embed this score on your blog
The VERU X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/VERU" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/VERU">VERU X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Public Trade Ledger — All Recorded Closed Outcomes
Cash-Secured Put ledger ↗ · See a sample →